Evidence map

ReviewPharmaceutical research2025

Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer Therapeutics.

Santosh Kumar Maurya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39775614